FLUOGUIDE A/S DK -1 Cash Flow Conversion Efficiency
FLUOGUIDE A/S DK -1 cash flow conversion efficiency. Based on the latest financial reports, FLUOGUIDE A/S DK -1 (96X) has a cash flow conversion efficiency ratio of -0.092x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-5.03 Million ≈ $-5.88 Million USD) by net assets (€54.53 Million ≈ $63.75 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of FLUOGUIDE A/S DK -1 (2021–2025)
Cash flow conversion efficiency of FLUOGUIDE A/S DK -1 from 2021 to 2025. This chart illustrates how FLUOGUIDE A/S DK -1's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 96X stock price for real-time trading data and today's change.
FLUOGUIDE A/S DK -1 Cash Flow Conversion Ratio Explained
FLUOGUIDE A/S DK -1 cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
FLUOGUIDE A/S DK -1 Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of FLUOGUIDE A/S DK -1 ranked by their cash flow conversion efficiency. Also see 96X market cap overview for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
TY Holdings Co Ltd
KO:363280
|
-0.031x |
|
CONCORD ENVIRO SYSTEMS L
NSE:CEWATER
|
-0.071x |
|
Kutahya Porselen Sanayi AS
IS:KUTPO
|
-0.056x |
|
Grazziotin S.A
SA:CGRA3
|
0.028x |
|
Univastu India Limited
NSE:UNIVASTU
|
-0.089x |
|
Precision Optics Corporation, Inc. Common stock
NASDAQ:POCI
|
-0.032x |
|
Townsquare Media Inc
NYSE:TSQ
|
-0.040x |
|
Everbrite Technology Co Ltd
TWO:4523
|
-0.042x |
Annual Cash Flow Conversion Efficiency for FLUOGUIDE A/S DK -1 (2021–2025)
The table below shows the annual cash flow conversion efficiency of FLUOGUIDE A/S DK -1 from 2021 to 2025. Review 96X financial flexibility index to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €54.53 Million ≈ $63.75 Million |
€-36.96 Million ≈ $-43.21 Million |
-0.678x | +46.37% |
| 2024-12-31 | €23.07 Million ≈ $26.97 Million |
€-29.15 Million ≈ $-34.08 Million |
-1.264x | +49.46% |
| 2023-12-31 | €12.72 Million ≈ $14.87 Million |
€-31.81 Million ≈ $-37.19 Million |
-2.501x | -112.36% |
| 2022-12-31 | €31.97 Million ≈ $37.37 Million |
€-37.65 Million ≈ $-44.01 Million |
-1.178x | -202.57% |
| 2021-12-31 | €38.70 Million ≈ $45.25 Million |
€-15.06 Million ≈ $-17.61 Million |
-0.389x | -- |
About FLUOGUIDE A/S DK -1
FluoGuide A/S, a clinical stage biotechnology company, develops drugs for precision cancer surgery in Denmark. The company offers FG001, an urokinase-type plasminogen activator receptor target imaging agent, which is in Phase II clinical trial for the treatment of high-grade glioma and lung, head, and neck cancer; and functions as a photosensitizer, which is in pre-clinical stage for the treatmen… Read more